Characterization of Hepatitis C Virus Resistance from a Multiple-Dose Clinical Trial of the Novel NS5A Inhibitor GS-5885
Supplemental material
Files in this Data Supplement:
Supplemental file 1
-
Table S1 and Fig. S1 and S2.
PDF, 278K